GLP-1 receptor agonists actively revolutionize obesity and Type-2 diabetes treatments by mimicking natural gut hormones to suppress appetite and control blood sugar. Despite profound cardiometabolic benefits, rapid weight loss triggers adverse effects, prompting strict global regulatory crackdowns against unauthorized usage.
Click to View MoreThe alarming surge in childhood obesity threatens India’s future health and economy. Urgent measures like front-of-pack labelling, regulating junk food ads, health taxes, and strengthening school nutrition reforms are vital to safeguard children’s right to balanced, nutritious food.
Click to View More
© 2026 iasgyan. All right reserved
